Clinical Trial Update: Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study [NA]

View source ↗

Summary

The DIACOR study evaluating diabetes and combined lipid therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mixed Dyslipidemia
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Intermountain Health Care, Inc. | Conditions: Type II Diabetes Mellitus, Mixed Dyslipidemia | NA | Status: COMPLETED